The Claim
Omega-3 fatty acid supplementation in patients with colorectal cancer is associated with a modest increase in serum albumin levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with colorectal cancer who take omega-3 fatty acid supplements have slightly higher levels of serum albumin in their blood.
See the scientific wording
Omega-3 fatty acid supplementation in patients with colorectal cancer is associated with a modest increase in serum albumin levels, indicating a potential benefit for nutritional status.
Omega-3 fatty acids replace other fats in cell membranes, which changes how immune cells signal, leading to less inflammation. This tells the liver to stop making inflammation markers and start making more albumin, a protein that helps maintain blood volume and nutrient transport.
What the research says
1 studyTaking omega-3 supplements may slightly raise a blood protein called albumin in people with colon cancer, which is a sign their body is getting better nutrition. The study found this small improvement happened after patients took omega-3s.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.